Skip to main content
Joel Blankson, MD, Infectious Disease, Baltimore, MD

Joel Nee-Lartley Blankson MD


Professor of Medicine, Johns Hopkins University School of Medicine

Join to view full profile
  • 1800 Orleans StreetBaltimore, MD 21287

  • Phone+1 410-955-5000

  • Fax+1 410-955-5001

Dr. Blankson is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Infectious Disease, 1998 - 2002
  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Internal Medicine, 1995 - 1998
  • Weill Cornell Medicine
    Weill Cornell MedicineClass of 1995

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 1998 - 2026
  • Infectious Disease
    American Board of Internal Medicine Infectious Disease

Awards, Honors, & Recognition

  • Elected Member The American Society for Clinical Investigation, 2012

Publications & Presentations

PubMed

Journal Articles

  • Interferon-Α Enhances NK Cell Function and the Suppressive Capacity of HIV-Specific CD8+ T Cells  
    Joel Blankson, MD, mBio
  • CMPK2 and BCL-G Are Associated with Type 1 Interferon–Induced HIV Restriction in Humans  
    Justin R. Bailey, Joel N. Blankson, Robert F. Siliciano, Stuart C. Ray, Ramy El-Diwany, Science Magazine
  • Highly Attenuated Infection with a Vpr-Deleted Molecular Clone of HIV-1  
    Peter A Anton, Jennifer A Fulcher, Otto O Yang, Joel N Blankson, The Journal of Infectious Diseases

Press Mentions

  • Researchers See Dramatic Drop in HIV-Infected Immune Cells in Patient After Cancer Treatment Received
    Researchers See Dramatic Drop in HIV-Infected Immune Cells in Patient After Cancer Treatment ReceivedDecember 15th, 2025
  • Breakthrough COVID Infections More Likely in People Living with HIV
    Breakthrough COVID Infections More Likely in People Living with HIVJune 9th, 2022
  • Antibodies from Covid Vaccines May Be Weaker Against Omicron, Study Finds
    Antibodies from Covid Vaccines May Be Weaker Against Omicron, Study FindsApril 27th, 2022

Grant Support

  • Identification and elimination of antigen-specific expanded clonesJOHNS HOPKINS UNIVERSITY2026–2028
  • Eradication of clonally expanded CD4+ T cellsJOHNS HOPKINS UNIVERSITY2022–2025
  • CD8+ T Cell Mediated Inhibition Of HIV-1 Replication In Elite SuppressorsNational Institute Of Allergy And Infectious Diseases2009–2012
  • Analysis Of HIV-1 In Mucosal Tissue In Elite SuppressorsNational Institute Of Allergy And Infectious Diseases2011
  • Characterization Of HIV Excape Mutants And T Cell Responses In Elite SuppressorsNational Institute Of Allergy And Infectious Diseases2007

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: